These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23454513)

  • 1. Synthesis and biochemical activities of antiproliferative amino acid and phosphate derivatives of microtubule-disrupting β-lactam combretastatins.
    O'Boyle NM; Greene LM; Keely NO; Wang S; Cotter TS; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2013 Apr; 62():705-21. PubMed ID: 23454513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe.
    O'Boyle NM; Carr M; Greene LM; Keely NO; Knox AJ; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2011 Sep; 46(9):4595-607. PubMed ID: 21840628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
    O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
    J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of cyclopropylamide analogues of combretastatin-A4 as novel microtubule-stabilizing agents.
    Chen H; Li Y; Sheng C; Lv Z; Dong G; Wang T; Liu J; Zhang M; Li L; Zhang T; Geng D; Niu C; Li K
    J Med Chem; 2013 Feb; 56(3):685-99. PubMed ID: 23356786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model.
    Gagné-Boulet M; Fortin S; Lacroix J; Lefebvre CA; Côté MF; C-Gaudreault R
    Eur J Med Chem; 2015 Jul; 100():34-43. PubMed ID: 26069928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
    Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
    Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
    Greene LM; Nathwani SM; Bright SA; Fayne D; Croke A; Gagliardi M; McElligott AM; O'Connor L; Carr M; Keely NO; O'Boyle NM; Carroll P; Sarkadi B; Conneally E; Lloyd DG; Lawler M; Meegan MJ; Zisterer DM
    J Pharmacol Exp Ther; 2010 Nov; 335(2):302-13. PubMed ID: 20699436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of antiproliferative microtubule-destabilising combretastatin A-4 piperazine conjugates.
    O'Boyle NM; Ana G; Kelly PM; Nathwani SM; Noorani S; Fayne D; Bright SA; Twamley B; Zisterer DM; Meegan MJ
    Org Biomol Chem; 2019 Jun; 17(25):6184-6200. PubMed ID: 31173031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
    Pettit GR; Anderson CR; Herald DL; Jung MK; Lee DJ; Hamel E; Pettit RK
    J Med Chem; 2003 Feb; 46(4):525-31. PubMed ID: 12570374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent microtubule-targeting agent: Synthesis and biological evaluation of water-soluble amino acid prodrug of combretastatin A-4 derivatives.
    Yu K; Li R; Yang Z; Wang F; Wu W; Wang X; Nie C; Chen L
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2302-7. PubMed ID: 25933592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity.
    Xu Q; Qi H; Sun M; Zuo D; Jiang X; Wen Z; Wang Z; Wu Y; Zhang W
    PLoS One; 2015; 10(6):e0128710. PubMed ID: 26061410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
    Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
    Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents.
    Greene TF; Wang S; Greene LM; Nathwani SM; Pollock JK; Malebari AM; McCabe T; Twamley B; O'Boyle NM; Zisterer DM; Meegan MJ
    J Med Chem; 2016 Jan; 59(1):90-113. PubMed ID: 26680364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents.
    Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B
    Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
    J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
    ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
    Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.